Results

Total Results: 2,639 records

Showing results for "absence".

  1. psnet.ahrq.gov/issue/conspicuous-its-absence-diagnostic-expert-testing-under-uncertainty
    February 28, 2024 - Commentary Conspicuous by its absence: diagnostic expert testing under uncertainty … Conspicuous by Its absence: diagnostic expert testing under uncertainty. … Conspicuous by Its absence: diagnostic expert testing under uncertainty.
  2. psnet.ahrq.gov/issue/absence-drug-disease-interaction-alert-leads-childs-death
    July 08, 2015 - Newspaper/Magazine Article The absence of a drug–disease interaction alert leads … Citation Text: The absence of a drug–disease interaction alert leads to a child's death. … Linkedin Copy URL Cite Citation Citation Text: The absence
  3. digital.ahrq.gov/ahrq-funded-projects/valuation-primary-care-integrated-telehealth/citation/telemedicine-reduces
    January 01, 2023 - Telemedicine reduces absence resulting from illness in urban child care: evaluation of an innovation. … Telemedicine reduces absence resulting from illness in urban child care: evaluation of an innovation. … Telemedicine reduces absence result… Principal Investigator McConnochie, Kenneth Project
  4. psnet.ahrq.gov/issue/absence-or-presence-silent-discourse-operating-room-and-impact-surgical-team-action
    June 23, 2021 - Study Absence or presence: silent discourse in the operating room and impact on surgical … Absence or presence: silent discourse in the operating room and impact on surgical team action. … Absence or presence: silent discourse in the operating room and impact on surgical team action.
  5. psnet.ahrq.gov/issue/fda-alerts-health-care-professionals-temporary-absence-warning-statement-vial-caps-two
    June 22, 2011 - Press Release/Announcement FDA alerts health care professionals to the temporary absence … Citation Text: FDA alerts health care professionals to the temporary absence of warning statement on … This announcement alerts clinicians to the absence of warning statements on two types of paralyzing agents … Citation Citation Text: FDA alerts health care professionals to the temporary absence
  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/60697/psn-pdf
    July 15, 2020 - FDA alerts health care professionals to the temporary absence of warning statement on the vial caps … https://psnet.ahrq.gov/issue/fda-alerts-health-care-professionals-temporary-absence-warning-statement … This announcement alerts clinicians to the absence of warning statements on two types of paralyzing … https://psnet.ahrq.gov/issue/fda-alerts-health-care-professionals-temporary-absence-warning-statement-vial-caps-two … https://psnet.ahrq.gov/issue/fda-alerts-health-care-professionals-temporary-absence-warning-statement-vial-caps-two
  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/61111/psn-pdf
    January 01, 2021 - Absence or presence: silent discourse in the operating room and impact on surgical team action. … Absence or presence: silent discourse in the operating room and impact on surgical team action. … https://psnet.ahrq.gov/issue/absence-or-presence-silent-discourse-operating-room-and-impact-surgical- … https://psnet.ahrq.gov/issue/absence-or-presence-silent-discourse-operating-room-and-impact-surgical-team-action … https://psnet.ahrq.gov/issue/absence-or-presence-silent-discourse-operating-room-and-impact-surgical-team-action
  8. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/60157/psn-pdf
    March 25, 2020 - Conspicuous by its absence: diagnostic expert testing under uncertainty. … Conspicuous by Its absence: diagnostic expert testing under uncertainty. … https://psnet.ahrq.gov/issue/conspicuous-its-absence-diagnostic-expert-testing-under-uncertainty This … https://psnet.ahrq.gov/issue/conspicuous-its-absence-diagnostic-expert-testing-under-uncertainty https
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - Absence of evidence is not evidence of absence. BMJ 1995 Aug;311(7003):485. … Estimating disease prevalence in the absence of a gold standard. … Inferences for likelihood ratios in the absence of a "gold standard". … Absence of evidence is not evidence of absence. BMJ 1995 Aug;311(7003):485. PMID: 7647644. … Estimating disease prevalence in the absence of a gold standard.
  10. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - Absence of evidence is not evidence of absence. BMJ 1995 Aug;311(7003):485. … Estimating disease prevalence in the absence of a gold standard. … Inferences for likelihood ratios in the absence of a "gold standard". … Absence of evidence is not evidence of absence. BMJ 1995 Aug;311(7003):485. PMID: 7647644. … Estimating disease prevalence in the absence of a gold standard.
  11. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/4_TK2_T2-Antibiotic_Pocket_Cards.pdf
    May 01, 2014 - How to Isolate Culture-positive Residents: • Do not use contact precautions in the absence of a draining … How To Isolate Culture-positive Residents: • Do not use contact precautions in the absence of a draining … “Infiltrate” on chest x-ray in the absence of clinically significant symptoms. 7. … Suspected or proven influenza in the absence of a secondary infection (but DO treat influenza with antivirals … Acute vomiting and/or diarrhea in the absence of a positive culture for shigella or salmonella, or a
  12. www.ahrq.gov/sites/default/files/2024-01/sangasubana-report.pdf
    January 01, 2024 - four side effects on label; (3) dry skin vs. diabetes as pre-existing health problem; and (4) absence … Info Presence Info Absence Info Presence Info Absence Info Presence Info Absence Probability … Info Presence Info Absence Info Presence Info Absence Info Presence Info Absence Probability … Info Presence Info Absence Info Presence Info Absence Info Presence Info Absence Other OTC … Info Presence Info Absence Info Presence Info Absence Info Presence Info Absence Other OTC
  13. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/27-hh4m-workgroup-charter-template.docx
    June 02, 2025 - by majority) will be made: · If a workgroup member misses a meeting, decisions will be made in their absence … The workgroup will decide on a case-by-case basis if a decision that is made in the absence of a workgroup
  14. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-1-tables-1-4.pdf
    June 02, 2025 - including location, intensity and description) prior to initiation of treatment or documentation of the absence … including location, intensity and description) prior to initiation of treatment or documentation of the absence … including location, intensity and description) prior to initiation of treatment or documentation of the absence
  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/44183/psn-pdf
    November 03, 2015 - The absence of a drug–disease interaction alert leads to a child's death. … https://psnet.ahrq.gov/issue/absence-drug-disease-interaction-alert-leads-childs-death The disabling … https://psnet.ahrq.gov/issue/absence-drug-disease-interaction-alert-leads-childs-death https://psnet.ahrq.gov
  16. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/uti-guide.docx
    September 01, 2022 - Furthermore, mental status changes in the absence of urinary symptoms are highly unlikely to indicate … obtain a urinalysis and urine cultures in febrile and irritable children in this age group, in the absence … The presence of pyuria in the absence of abnormal urinary symptoms also does not indicate a UTI. … Although pyuria without relevant urinary symptoms make the diagnosis of a UTI unlikely, the absence of … Since the presence of WBCs or bacteria in the urine in the absence of relevant clinical symptoms does
  17. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
    June 02, 2025 - • Tachycardia, defined as a mean heart rate > 2 SD above normal for age in the absence of external … for children <1 yr old: bradycardia, defined as a mean heart rate <10th percentile for age in the absence … refill: > 5 seconds – Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence
  18. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
    June 02, 2025 - • Tachycardia, defined as a mean heart rate > 2 SD above normal for age in the absence of external … for children <1 yr old: bradycardia, defined as a mean heart rate <10th percentile for age in the absence … refill: > 5 seconds – Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence
  19. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
    June 02, 2025 - • Tachycardia, defined as a mean heart rate > 2 SD above normal for age in the absence of external … for children <1 yr old: bradycardia, defined as a mean heart rate <10th percentile for age in the absence … refill: > 5 seconds – Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence
  20. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/838135/psn-pdf
    January 01, 2023 - scenarios describing a hypothetical patient with symptoms suggestive of COVID-19 in the presence or absence … alternative diagnosis (e.g., COVID-19 symptoms and the presence or absence of a positive flu test).